85 related articles for article (PubMed ID: 20459571)
1. High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma.
Sartelet H; Ohta S; Barrette S; Rougemont AL; Brevet M; Regairaz M; Harvey I; Bernard C; Fabre M; Gaboury L; Oligny LL; Bosq J; Valteau-Couanet D; Vassal G
Histopathology; 2010 Apr; 56(5):607-16. PubMed ID: 20459571
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin decreases Raf-1 and Akt levels and induces apoptosis in neuroblastomas.
Kim S; Kang J; Hu W; Evers BM; Chung DH
Int J Cancer; 2003 Jan; 103(3):352-9. PubMed ID: 12471618
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase suppression protects rheumatoid synovial fibroblasts from Fas-induced apoptosis.
García S; Mera A; Gómez-Reino JJ; Conde C
Rheumatology (Oxford); 2009 May; 48(5):483-9. PubMed ID: 19228791
[TBL] [Abstract][Full Text] [Related]
4. Increased occurrence of caspase-dependent apoptosis in unfavorable neuroblastomas.
Koizumi H; Hamano S; Doi M; Tatsunami S; Nakada K; Shinagawa T; Tadokoro M
Am J Surg Pathol; 2006 Feb; 30(2):249-57. PubMed ID: 16434901
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
[TBL] [Abstract][Full Text] [Related]
6. UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines.
Shankar SL; Krupski M; Parashar B; Okwuaka C; O'Guin K; Mani S; Shafit-Zagardo B
J Neurochem; 2004 Aug; 90(3):702-11. PubMed ID: 15255949
[TBL] [Abstract][Full Text] [Related]
7. Activation of Akt predicts poor outcome in neuroblastoma.
Opel D; Poremba C; Simon T; Debatin KM; Fulda S
Cancer Res; 2007 Jan; 67(2):735-45. PubMed ID: 17234785
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling protects retina from nuclear factor-κB- and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation.
Qin X; Zhang Z; Xu H; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):703-11. PubMed ID: 21813561
[TBL] [Abstract][Full Text] [Related]
9. Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcome.
Hedborg F; Bjelfman C; Sparén P; Sandstedt B; Påhlman S
Eur J Cancer; 1995; 31A(4):435-43. PubMed ID: 7576941
[TBL] [Abstract][Full Text] [Related]
10. [Study on MYCN gene amplification and CD44 expression in neuroblastoma].
Hu HL; He LJ
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):332-6. PubMed ID: 15363318
[TBL] [Abstract][Full Text] [Related]
11. Different characteristics of neuroblastomas in cases found by mass screening and non-screening: evaluation of mass screening for neuroblastoma in Kitakyushu City.
Ariyoshi N
J UOEH; 1993 Dec; 15(4):251-66. PubMed ID: 8265887
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Mikami M; Taniguchi H; Takahashi T; Adachi Y; Imamura A; Imai K; Shinomura Y
Eur J Cancer; 2006 Sep; 42(14):2374-81. PubMed ID: 16809031
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling.
Wang SJ; Wang SH; Song ZF; Liu XW; Wang R; Chi ZF
Neuroreport; 2007 Aug; 18(12):1285-9. PubMed ID: 17632284
[TBL] [Abstract][Full Text] [Related]
14. Maturation of mass-screened localized adrenal neuroblastoma.
Iwanaka T; Yamamoto K; Ogawa Y; Arai M; Ito M; Kishimoto H; Hanada R; Imaizumi S
J Pediatr Surg; 2001 Nov; 36(11):1633-6. PubMed ID: 11685689
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan.
Tajiri T; Souzaki R; Kinoshita Y; Tanaka S; Koga Y; Suminoe A; Matsuzaki A; Hara T; Taguchi T
J Pediatr Surg; 2009 Dec; 44(12):2253-7. PubMed ID: 20006005
[TBL] [Abstract][Full Text] [Related]
16. Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.
Bjellerup P; Theodorsson E; Jörnvall H; Kogner P
Br J Cancer; 2000 Jul; 83(2):171-6. PubMed ID: 10901366
[TBL] [Abstract][Full Text] [Related]
17. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
18. Correlation of MYCN amplification with MCM7 protein expression in neuroblastomas: a chromogenic in situ hybridization study in paraffin sections.
Tsai HY; Hsi BL; Hung IJ; Yang CP; Lin JN; Chen JC; Tsai SF; Huang SF
Hum Pathol; 2004 Nov; 35(11):1397-403. PubMed ID: 15668898
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
Kerbl R; Urban CE; Ambros IM; Dornbusch HJ; Schwinger W; Lackner H; Ladenstein R; Strenger V; Gadner H; Ambros PF
J Clin Oncol; 2003 Nov; 21(22):4228-34. PubMed ID: 14615452
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo.
Johnsen JI; Segerström L; Orrego A; Elfman L; Henriksson M; Kågedal B; Eksborg S; Sveinbjörnsson B; Kogner P
Oncogene; 2008 May; 27(20):2910-22. PubMed ID: 18026138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]